Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cardlytics, Inc. Director's Dealing 2020

Feb 26, 2020

33956_dirs_2020-02-26_2ac86850-bc46-4ebb-a0ad-2f05ef1ca3d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-02-24

Reporting Person: Grimes Scott D. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-24 Common Stock S 1000 $90 Disposed 139112 Indirect
2020-02-25 Common Stock S 800 $83.44 Disposed 386403 Direct
2020-02-25 Common Stock S 3116 $84.60 Disposed 383287 Direct
2020-02-25 Common Stock S 581 $85.47 Disposed 382706 Direct
2020-02-25 Common Stock S 200 $87.13 Disposed 382506 Direct
2020-02-25 Common Stock S 2803 $88.49 Disposed 379703 Direct
2020-02-25 Common Stock S 2000 $89.23 Disposed 377703 Direct
2020-02-25 Common Stock S 200 $90.17 Disposed 377503 Direct
2020-02-25 Common Stock S 100 $91.36 Disposed 377403 Direct
2020-02-25 Common Stock S 200 $92.56 Disposed 377203 Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019.

F2: The reportable securities are held by the GRAT.

F3: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended May 14, 2019.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $83.12 to $83.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), (6), (7), (8), (9), (10), (11) and (12) to this Form 4.

F5: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $84.14 to $84.93, inclusive.

F6: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $85.19 to $85.69, inclusive.

F7: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $86.75 to $87.505, inclusive.

F8: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $87.83 to $88.80, inclusive.

F9: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $88.88 to $89.86, inclusive.

F10: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.96 to $90.37, inclusive.

F11: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.36 to $91.47, inclusive.

F12: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.40 to $92.71, inclusive.